Walleye Trading’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Walleye Trading’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-57,995	Closed	-$135K	–	4737
2020 Q1	$135K	Buy	+57,995	New	+$159K	﹤0.01%	2918
2019 Q2	–	Sell	-475	Closed	-$5K	–	4640
2019 Q1	$5K	Sell	475 -8,311	-95%	-$89K	﹤0.01%	4047
2018 Q4	$77K	Buy	+8,786	New	+$112K	﹤0.01%	3998
2018 Q3	–	Sell	-18,771	Closed	-$393K	–	5635
2018 Q2	$393K	Buy	+18,771	New	+$348K	﹤0.01%	3057
2017 Q2	–	Sell	-46,700	Closed	-$304	–	5076
2017 Q1	$304	Buy	+46,700	New	+$261K	﹤0.01%	2634
2015 Q4	–	Sell	-17	Closed	–	–	5821
2015 Q3	$0	Buy	+17	New	+$118	﹤0.01%	5643

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Walleye Trading's SPPI Position: Q2 2020 in Review

Walleye Trading sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2020, closing a stake of 57,995 shares — an estimated $135K sold.

Walleye Trading first reported a position in SPPI in Q3 2015 and held it in 6 quarters. The position peaked at $393K in Q2 2018. 158 funds tracked by Wall St. Rank hold SPPI as of Q2 2020.

Walleye Trading reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Walleye Trading sold 57,995 Spectrum Pharmaceuticals Inc shares in Q2 2020, an estimated $135K.
Walleye Trading first reported a position in Spectrum Pharmaceuticals Inc in Q3 2015 and held it in 6 quarters.
Walleye Trading's Spectrum Pharmaceuticals Inc position peaked at $393K in Q2 2018.
158 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2020.

Based on Walleye Trading's 13F filing for Q2 2020, filed 14 Aug 2020.